• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Happiness Development Group Limited (Amendment)

    7/28/23 4:15:28 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $HAPP alert in real time by email
    SC 13D/A 1 ea182533-13da1wang_parano.htm AMENDMENT NO. 1 TO SCHEDULE 13D

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    AMENDMENT NO. 1 TO

    SCHEDULE 13D

     

    Under the Securities Exchange Act of 1934

     

    Paranovus Entertainment Technology Limited

    (Name of Company)

     

    Class B Ordinary Shares, $0.01 Par Value

    (Title of Class of Securities)

     

    N/A

    (CUSIP Number)

     

    Xuezhu Wang

    No. 11, Dongjiao East Road, Shuangxi,

    Shunchang, Nanping City, Fujian Province,

    People’s Republic of China

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

    September 8, 2022

    (Date of Event which Requires Filing of this Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box ☐

     

    The information required on the remainder of this cover page shall not be deemed to be ‘filed’ for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however see the Notes).

     

     

     

     

     

    CUSIP Number: N/A

     

    1 NAME OF REPORTING PERSON
      I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
       
      Happy Group Inc.
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
      (a) ☐  
      (b) ☐  
       
    3 SEC USE ONLY
       
       
    4 SOURCE OF FUNDS
       
      WC
       
    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ☐
       
       
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
       
      Cayman Islands
        7 SOLE VOTING POWER
           
           602,255
    NUMBER OF      
    SHARES   8 SHARED VOTING POWER
    BENEFICIALLY      
    OWNED BY     0
    EACH      
    REPORTING   9 SOLE DISPOSITIVE POWER
    PERSON WITH      
          602,255
           
        10

    SHARED DISPOSITIVE POWER

     

           0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
      602,255
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐
       
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
      98.37% (1)
    14 TYPE OF REPORTING PERSON
       
      FI
             

    (1) Percentage is calculated based on the Issuer’s prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) on July 27, 2023, which discloses that the total number of outstanding Class B ordinary shares as of July 27, 2023 was 612,255.

     

    2

     

     

    CUSIP Number: N/A

     

    1 NAME OF REPORTING PERSON
      I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
       
      Xuezhu Wang
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
      (a) ☐  
      (b) ☐  
       
    3 SEC USE ONLY
       
       
    4 SOURCE OF FUNDS
       
      AF
       
    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ☐
       
       
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
       
      China
        7 SOLE VOTING POWER
           
          10,000
    NUMBER OF      
    SHARES   8 SHARED VOTING POWER
    BENEFICIALLY      
    OWNED BY     602,255
    EACH      
    REPORTING   9 SOLE DISPOSITIVE POWER
    PERSON WITH      
          10,000
           
        10 SHARED DISPOSITIVE POWER
           
            602,255
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
      612,255
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐
       
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
      100% (1)
    14 TYPE OF REPORTING PERSON
       
      IN

     

    (1) Percentage is calculated based on the Issuer’s prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) on July 27, 2023, which discloses that the total number of outstanding Class B ordinary shares as of July 27, 2023 was 612,255.

     

    3

     

     

    CUSIP Number: N/A

     

    1 NAME OF REPORTING PERSON
      I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
       
      Minzhu Xu
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
      (a) ☐  
      (b) ☐  
       
    3 SEC USE ONLY
       
       
    4 SOURCE OF FUNDS
       
      PF
       
    5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ☐
       
       
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
       
      China
        7 SOLE VOTING POWER
           
           0
    NUMBER OF      
    SHARES   8 SHARED VOTING POWER
    BENEFICIALLY      
    OWNED BY     0
    EACH      
    REPORTING   9 SOLE DISPOSITIVE POWER
    PERSON WITH      
          0
           
        10

    SHARED DISPOSITIVE POWER

     

           0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
       
      0
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐
       
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
       
      0% (1)
    14 TYPE OF REPORTING PERSON
       
      IN
             

    (1) Percentage is calculated based on the Issuer’s prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) on July 27, 2023, which discloses that the total number of outstanding Class B ordinary shares as of July 27, 2023 was 612,255.

     

    4

     

     

    Item 1. Security and Issuer.

     

    This amendment No.1 to the Schedule 13D (“Schedule 13D/A”) relates to the Class B ordinary shares, par value $0.01 per share (the “Class B Ordinary Shares”) of Paranovus Entertainment Technology Limited, a Cayman Islands corporation (the “Issuer”), whose principal executive office is located at No. 11, Dongjiao East Road, Shuangxi, Shunchang, Nanping City, Fujian Province, People’s Republic of China.

     

    Item 2. Identity and Background.

     

      (a) The Statement is jointly filed by Happy Group Inc., Xuezhu Wang, and Minzhu Xu (each, a “Reporting Person,” together, the “Reporting Persons”). Xuezhu Wang is the sole director and was the sole shareholder of Happy Group Inc. Minzhu Xu is the sole shareholder of Happy Group Inc.

     

      (b) The Happy Group Inc.’s and Xuezhu Wang’s principal business address is No. 11, Dongjiao East Road, Shuangxi, Shunchang, Nanping City, Fujian Province, People’s Republic of China. Minzhu Xu’s principal business address is North Tianewan, Building 10, Apartment 1903, Chaoyang District, Beijing, People’s Republic of China.

      

      (c) The Reporting Persons are currently significant stockholders of the Issuer. The principal occupation of Xuezhu Wang is being the Chief Executive Officer and director of the Issuer. Xuezhu Wang is the sole director of Happy Group Inc. Minzhu Xu is the sole shareholder of Happy Group Inc.

     

      (d) During the past five years, none of the Reporting Persons or to the knowledge of the Reporting Persons, the persons identified in this Item 2, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

     

      (e) During the past five years, none of the Reporting Persons or to the knowledge of the Reporting Persons, the persons identified in this Item 2, has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was the subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal and state securities laws of findings any violation with respect to such laws.

     

      (f) Happy Group Inc. is a company incorporated in Cayman Islands. Xuezhu Wang is a citizen of People’s Republic of China. Minzhu Xu is a citizen of People’s Republic of China.

      

    Item 3. Source and Amount of Funds and Other Consideration.

     

    On March 4, 2019, Happy Group Inc. acquired 12,045,100 ordinary shares of the Issuer, par value $0.0005 each, in a private transaction pursuant to the exemption from registration available under Section 4(a)(2) of the Securities Act and Regulation S promulgated thereunder. As a result, Xuezhu Wang indirectly owns and controls 12,045,100 ordinary shares of the Issuer, par value $0.0005 each, through his 100% ownership of Happy Group Inc.

     

    In October 2021 and October 2022, the Issuer re-designate its ordinary shares into Class A ordinary shares and Class B ordinary shares and completed a share combination at the ratio of 1:20, respectively. As a result, the Issuer’s authorized capital consists of 350,000,000 Class A ordinary shares of $0.01 par value each and 100,000,000 Class B ordinary shares with a par value of US $0.01 each, and 50,000,000 ordinary shares with a par value of $0.01 each.

     

    On September 8, 2022, Minzhu Xu purchased all Happy Group Inc.’s outstanding shares from Xuezhu Wang for an aggregate consideration of $50,000, and agreed that as the sole shareholder of Happy Group Inc., Minzhu Xu irrevocably agreed that she would not remove Mr. Xuezhu Wang as the sole director of Happy Group Inc. for 15 months following the share transfer.  Therefore, Mr. Wang continues to have the voting control and investment discretion over the shares held by Happy Group Inc. and remains as the beneficiary owner of these shares.

      

    Item 4. Purpose of Transaction.

     

    The purpose of the acquisition is for investment only. The Reporting Persons may make further acquisitions of the Issuer’s Class A ordinary shares or Class B ordinary shares from time to time and, subject to certain restrictions, may dispose of any or all of the Class B ordinary shares held by the Reporting Persons at any time depending on an ongoing evaluation of the investment in such securities, prevailing market conditions, other investment opportunities and other factors.

     

    Except for the foregoing and except in Xuezhu Wang’s capacity as the Chief Executive Officer and a director of the Issuer and the beneficial owner of 612,255 Class B ordinary shares of the Issuer, as of the date of this Schedule 13D/A, the Reporting Persons do not have any plans or proposals which relate to or would result in:

     

      (a) the acquisition by any person of additional securities of the Issuer;

     

      (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;

     

    5

     

     

      (c) a sale or transfer of a material amount of assets of the Issuer or of any of its subsidiaries;

     

      (d) any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number of terms of directors or to fill any existing vacancies on the board;

     

      (e) any material change in the present capitalization or dividend policy of the Issuer;

      

      (f) any other material change in the Issuer’s business or corporate structure;

     

      (g) changes in the Issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any other person;

     

      (h) causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;

     

      (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or

     

      (j) any similar action to those enumerated above.

     

    Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Company.

     

    The following descriptions are qualified in their entirety by the agreements and instruments included as exhibits to this Schedule 13D/A.

     

    The Reporting Persons are parties to an agreement with respect to the joint filing of this Schedule 13D/A and any amendments hereto. A copy of such agreement is attached as Exhibit 7.1 and is incorporated by reference herein.

     

    To the knowledge of the Reporting Persons, there are no other contracts, arrangements, understandings or relationships among the persons named in Item 2 with respect to any securities of the Issuer, except as described herein. 

     

    Item 7.   Material to be Filed as Exhibits.
    Exhibit 7.1*   Joint Filing Agreement, dated July 28, 2023

     

    * filed herewith

     

    [The remainder of this page is left blank intentionally.]

     

    6

     

      

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

     

    Date: July 28, 2023

     

      Xuezhu Wang
         
      By:  /s/ Xuezhu Wang
      Name:  Xuezhu Wang

     

        Happy Group Inc.

     

      By:  /s/ Xuezhu Wang
      Name: 

    Xuezhu Wang

    Sole Director

     

      Minzhu Xu
         
      By:  /s/ Minzhu Xu
      Name:  Minzhu Xu

     

     

    7

     

    Get the next $HAPP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HAPP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HAPP
    SEC Filings

    View All

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    1/23/24 4:15:34 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    1/12/24 4:15:56 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Happiness Development Group Limited

    6-K - Paranovus Entertainment Technology Ltd. (0001751876) (Filer)

    12/5/23 5:25:25 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    $HAPP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Happiness Development Group Limited Announces Name Change to Paranovus Entertainment Technology Ltd.

    NANPING, China, March 13, 2023 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) is pleased to announce that effective on March 14, 2023, the Company will change its name to "Paranovus Entertainment Technology Ltd.", which better reflects the Company's strategic business expansion and less limiting than the current name. In connection with the name change, the trading symbol of the Class A ordinary shares will be changed to "PAVS" on the Nasdaq Stock Market, effective on March 14, 2023. Xuezhu Wang, the CEO and the Chairman of the Board of the Company, commented, "This new name will reflect the company's evolving focus and strategy. The company is p

    3/13/23 9:10:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

    NANPING, China, Oct. 27, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) announced today that on October 25, 2022, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq's minimum bid price requirement and the matter is closed. On November 11, 2021, the Company was first notified by Nasdaq its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A), and was given its first 180-day extension, or until May 10, 2

    10/27/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Development Group Limited Announces 1 for 20 Reverse Share Split

    NANPING, China, Oct. 10, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) an emerging and diversified company engaging in the business of production and sale of nutraceutical and dietary supplements, providing e-commerce sales and marketing solutions, and the sales of automobile today announced that an 1 for 20 reverse split of its ordinary shares, par value $0.0005 each, was approved by the Company's shareholders on October 7, 2022 and became effective on October 10, 2022. In connection with the reverse share split, the Company's shareholders will receive one new ordinary share of the Company for every twenty shares they hold. The Company's o

    10/10/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    $HAPP
    Financials

    Live finance-specific insights

    View All

    Happiness Development Announces Financial Results for the Six Months Ended September 30, 2021

    NANPING, China, Jan. 6, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ:HAPP) a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce sales and e-commerce marketing solutions, and the sales of automobile today announced its unaudited financial results for the six months ended September 30, 2021. Financial Highlights for the six months ended September 30, 2021: Revenues increased by $25.01 million or 114.3%, to $46.88 million for the six months ended September 30, 2021 from $21.88 million for the six months ended September 30, 2020, mainly due to the start-up of new goods or service

    1/6/22 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Biotech Acquires Majority Ownership in Fujian Shennong

    NANPING, China, Oct. 25, 2021 /PRNewswire/ -- Happiness Biotech Group Limited ((the ", Company", NASDAQ:HAPP), a China-based company engaging in the business of production of nutraceutical and dietary supplements, providing e-commerce solutions, and the sales of automobile, today announced that it and its wholly owned-subsidiary, Fujian Happiness Biotech Co., Limited ("Happiness Fujian") have signed a share transfer agreement (the "Agreement") to acquire 70% of the equity interest in Fujian Shennong Jiagu Development Co., Ltd. ("Fujian Shennong") to further strengthen the Company's industrial integration. Fujian Shennong is a company with a solid customer's base, focusing on the trading of a

    10/25/21 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    Happiness Biotech Announces Financial Results for the Six Months Ended September 30, 2020 and Provides Guidance For the Whole Fiscal Year Ending March 31, 2021

    NANPING, China, Jan. 22, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" orNasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months ended September 30, 2020 and provided the guidance for the whole fiscal year ending March 31, 2021. Financial Highlights for the six months ended September 30, 2020: Revenues decreased by $9.48 million or 30.2%, to $21.88 million for the six months ended September 30, 2020 from $31.36 million for the six months ended September 30, 2019, mainly due to the declining retail market affected by the COVID-19. Operating income was $3.69 million fo

    1/22/21 8:00:00 AM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    $HAPP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Happiness Development Group Limited

    SC 13G - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    10/12/23 5:48:39 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Happiness Development Group Limited

    SC 13G - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    10/12/23 5:52:26 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D/A filed by Happiness Development Group Limited (Amendment)

    SC 13D/A - Paranovus Entertainment Technology Ltd. (0001751876) (Subject)

    7/28/23 4:15:28 PM ET
    $HAPP
    Medicinal Chemicals and Botanical Products
    Health Care